middle.news

Why Is Mach7 Technologies Buying Back Shares Amid Slight Revenue Risks?

8:49am on Thursday 10th of July, 2025 AEST Healthcare Technology
Read Story

Why Is Mach7 Technologies Buying Back Shares Amid Slight Revenue Risks?

8:49am on Thursday 10th of July, 2025 AEST
Key Points
  • FY25 revenue expected between A$33M and A$34M, aligning with guidance
  • Recurring revenue grows approximately 20%, driving overall growth
  • Contracted Annual Recurring Revenue (CARR) slightly below target at A$30M–31M
  • Operating expenses growth remains below revenue growth
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Mach7 Technologies (ASX:M7T)
OPEN ARTICLE